News | Nuclear Imaging | September 27, 2018

Technology and Radionucleotide Development Will Fuel Mobile Gamma Camera Adoption

New high-sensitivity PET tracers, trends toward solid state and dual-head gamma cameras expected to push total market revenue past $75 million by 2029

Technology and Radionucleotide Development Will Fuel Mobile Gamma Camera Adoption

September 27, 2018 — Advancements in healthcare technology, particularly in the surgery category, have led to an increasing adoption of gamma cameras. Further, the numerous developments in radionucleotides are anticipated to favor the adoption of solid state cameras and mobile gamma cameras. These findings are presented in a new research study on the global mobile gamma cameras market by Future Market Insights (FMI).

Single photon emission computed tomography (SPECT) is currently the biggest application of gamma cameras given the low cost, large suite of radioisotopes and expanded use cases. According to FMI, however, positron emission tomography (PET) is anticipated to witness the fastest growth in terms of adoption, owing to the greater special resolution and sensitivity brought about by the use of positron emitting radioisotopes that provide more energy, contrast and special resolution.

According to FMI analysis, the high costs of PET as compared to SPECT are expected to be negated in the wake of development of high sensitivity and selective tracers. FMI predicts a growth rate of 4.8 percent for the mobile gamma cameras market during the 10-year period from 2018 to 2028. Revenue from the sales of mobile gamma cameras is estimated to reach $75.2 million by the end of 2028, up from $47.2 million in 2018.

Being a high-value, low-volume market, technology plays a vital role in the mobile gamma cameras market, where the technologically advanced products are priced at a premium. The development of solid state sensors is slowly replacing the photomultiplier tube and this represents the biggest technological development in the market followed by miniaturization.

A notable trend being observed in the market is the shift towards dual-head gamma cameras. Single-head mobile gamma cameras have certain inherent disadvantages such as slow speed and lower density count, leading to the inability to perform different types of tests. This has resulted in an elevated demand for multiple-head cameras. Dual-head cameras increase total counts per stop, resulting in relatively lesser scan time and better image quality, leading to enhanced accuracy in diagnosis.

Further, according to FMI, the latest mobile gamma cameras come with newer and better functionalities. Owing to advances in electronic components and software, modern mobile gamma cameras include advanced reconstruction algorithms and periodic updates that help boost scan speeds and image correction parameters. Advanced gamma camera software also facilitates more personalized patient scans by tracking patient activity and performing appropriate scans.

The full market intelligence outlook from FMI can be downloaded here.

For more information: www.futuremarketinsights.com

Related Content

CORAR Supports Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2018
News | Radiopharmaceuticals and Tracers | October 12, 2018
October 12, 2018 — The Council on Radionuclides and Radiopharmaceuticals Inc.
Huntsman Cancer Institute Installs First Preclinical nanoScan 3T PET/MRI in U.S.
News | PET-MRI | October 10, 2018
The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI) at the University of Utah in Salt Lake...
Bruker Introduces New High-Performance Preclinical PET/CT Si78 System
Technology | PET-CT | September 26, 2018
September 26, 2018 — Bruker recently announced the introduction of the new preclinical...
Lightvision near-infrared fluorescence imaging system
News | Women's Health | September 11, 2018
Shimadzu Corp.
The Siemens Biograph Vision PET-CT system was released in mid-2018.

The Siemens Biograph Vision PET-CT system was released in mid-2018.

Feature | Nuclear Imaging | September 07, 2018 | By Dave Fornell
Nuclear imaging technology for both single photon emission computed tomography (SPECT) and positron emission tomography...
PET Imaging Agent Predicts Brain Tau Pathology, Alzheimer's Diagnosis
News | PET Imaging | September 05, 2018
Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of positron emission tomography (PET)...
Brain Study of 62,454 Scans Identifies Drives of Brain Aging
News | SPECT Imaging | August 27, 2018
In the largest known brain imaging study, scientists from five institutions evaluated 62,454 brain single photon...
Abnormal Protein Concentrations Found in Brains of Military Personnel With Suspected CTE

Researchers are using the tracer, which is injected into a patient, then seen with a PET scan, to see if it is possible to diagnose chronic traumatic encephalopathy in living patients. In this image, warmer colors indicate a higher concentration of the tracer, which binds to abnormal proteins in the brain. Credit UCLA Health.

News | PET Imaging | August 24, 2018
August 24, 2018 — In a small study of
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
Novel PET Imaging Method Could Track and Guide Type 1 Diabetes Therapy
News | PET Imaging | August 03, 2018
Researchers have discovered a new nuclear medicine test that could improve care of patients with type 1 diabetes. The...